Sign in
Join
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
TSM
Thursday, June 1, 2023
THE SHINING MEDIA
TRUE JOURNALISM. REAL JOURNALISM.
Business
Companies
Finance
Investing
Earnings
Fintech
Funds and ETFs
Personal Finance
Market
Market Insider
Technology
Gadgets
Internet
Social Media
Telecom
Others
Nation
World
Fashion & Lifestyle
Job & Education
Entertainment
Sports
Economy
Search
Tags
Paris Stock Exchange:SAN
Tag:
Paris Stock Exchange:SAN
Market
Press Release: Sanofi launches 2023 global Employee Stock Purchase Plan Â
GlobeNewswire
-
June 1, 2023
Market
Press Release: Annual General Meeting of May 25, 2023 – Frédéric Oudéa new Chairman of the Board of Directors
GlobeNewswire
-
May 25, 2023
Market
Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine
GlobeNewswire
-
May 21, 2023
Market
Press Release: Nirsevimab delivers 83% reduction in RSV infant hospitalizations in a real-world clinical trial setting
GlobeNewswire
-
May 12, 2023
Market
Sanofi: Information concerning the total number of voting rights and shares – March 2023
GlobeNewswire
-
April 20, 2023
Market
Press Release: Sanofi announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire...
GlobeNewswire
-
April 11, 2023
Market
Press Release: Dupixent® (dupilumab) late-breaking data at AAD show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis
GlobeNewswire
-
March 18, 2023
Market
Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients...
GlobeNewswire
-
March 17, 2023
Market
Information concerning the total number of voting rights and shares – February 2023
GlobeNewswire
-
March 14, 2023
Market
Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes...
GlobeNewswire
-
March 13, 2023
1
2
3
Page 1 of 3
- Advertisment -
Most Read
Resolutions adopted by the Annual General Meeting of Shareholders of AS Tallinna Vesi 01.06.2023
June 1, 2023
Panic at Mumbai Airport as a woman claims to have bomb
June 1, 2023
Li Auto Inc. May 2023 Delivery Update
June 1, 2023
CNH Industrial announces Senior Leadership Team appointment
June 1, 2023
error: